Silver nanoparticles and their antibacterial applications

Throughout history, silver, in its various forms, has held a prominent role as an antimicrobial agent, either on its own or in combination with other technologies. Silver nanoparticles (AgNPs), characterized as nanomaterials with dimensions falling within the range of 1–100 nm, have emerged as particularly noteworthy. These minuscule structures exhibit significantly increased surface area compared to bulk silver, owing to their nanoscale properties. At this scale, AgNPs display unique electrical, optical, and catalytic characteristics, which have prompted extensive research and the development of products geared towards targeted drug delivery, diagnostics, detection, and imaging. Researchers from Chile have delved into the factors influencing the antibacterial and cytotoxic effects of silver nanoparticles, shedding light on their remarkable properties. According to their findings, AgNPs demonstrate potent antibacterial activity against a spectrum of both Gram-positive and Gram-negative bacteria.
The literature currently supports primarily three mechanisms through which AgNPs wield their antibacterial prowess. Firstly, AgNPs can interact with sulfur-containing proteins present in the bacterial cell wall, disrupting critical functions. Secondly, these nanoparticles have the capacity not only to breach and traverse the bacterial cell membrane but also to infiltrate the interior of the cell, further compromising its integrity. Concurrently, a third mechanism involves the gradual release of silver ions from the nanoparticles. These liberated ions interact with various cellular components, leading to alterations in metabolic pathways. For a deeper exploration of these mechanisms and their implications, you can find additional information through the provided link.